Stock Research: Rohto Pharmaceutical

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Rohto Pharmaceutical

TSE:4527 JP3982400008
48
  • Value
    31
  • Growth
    73
  • Safety
    Safety
    42
  • Combined
    42
  • Sentiment
    57
  • 360° View
    360° View
    48
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

ROHTO PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in health and beauty care. It primarily provides eye care products (eye drops, lotions), skin care products (dermatological preparations, lip balms, sunscreens, functional cosmetics), oral medication, and food-related products (digestive medicines, Chinese herbal medicines, supplements), as well as extracorporeal test drugs. The company operates in domestic and overseas markets, including Europe, Asia, and America. In the last fiscal year, the company had 9144 employees, a market cap of $3254 million, profits of $1167 million, and revenue of $2058 million.

more
Index
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
31 59 40 51
Growth
73 24 35 33
Safety
Safety
42 75 82 77
Sentiment
57 56 16 49
360° View
360° View
48 65 36 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
36 30 51 33
Opinions Change
66 50 6 50
Pro Holdings
n/a 96 64 97
Market Pulse
48 41 42 38
Sentiment
57 56 16 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
31 59 40 51
Growth
73 24 35 33
Safety Safety
42 75 82 77
Combined
42 69 56 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
56 62 51 49
Price vs. Earnings (P/E)
36 52 42 56
Price vs. Book (P/B)
33 34 37 59
Dividend Yield
45 52 39 31
Value
31 59 40 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
35 69 31 32
Profit Growth
59 30 53 38
Capital Growth
100 22 35 63
Stock Returns
35 41 77 53
Growth
73 24 35 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
34 69 69 66
Refinancing
39 34 47 33
Liquidity
71 77 84 82
Safety Safety
42 75 82 77

Similar Stocks

Discover high‑ranked alternatives to Rohto Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Megmilk Snow Brand

TSE:2270
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

KOSÉ

TSE:4922
Country: Japan
Industry: Personal Products
Size: Medium
Full Stock Analysis

Maruha Nichiro

TSE:1333
Country: Japan
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: